Strong Balance Sheet Stocks

Results

94

6 new

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

94 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	ART	€29.10	-2.7%	150.9%	€1.7b	€34.25	29.9	21.0%	0.6%	Capital Goods
	SCGLR New	€19.80	0%	n/a	€97.0m	n/a	1.0	n/a	0.9%	Real Estate
	PHM	€78.80	0.4%	-2.7%	€1.4b	€104.39	24.3	37.2%	1.3%	Pharmaceuticals & Biotech
	DOMO	€1.39	0%	12.1%	€15.7m	n/a	0.8	n/a	0%	Real Estate Management and Development
	YINB2	€0.99	0%	1.0%	€24.6m	n/a	1.1	n/a	0.3%	Real Estate
	DESA	€24.20	0%	46.7%	€43.1m	€26.80	10.4	-2.9%	4.6%	Capital Goods
	PRM	€13.40	0.8%	8.9%	€228.0m	€16.75	13.7	7.7%	3.5%	Healthcare
	UBS	€0.0021	0%	-38.2%	€98.1m	n/a	0.6	n/a	n/a	Real Estate Management and Development
	EBRO	€18.32	0.3%	7.3%	€2.8b	€20.40	12.7	2.0%	3.8%	Food, Beverage & Tobacco
	NTH	€2.57	1.2%	38.2%	€154.1m	n/a	15.3	n/a	7.8%	Retail
	ACS New	€110.80	3.1%	86.5%	€30.7b	€127.48	30.4	14.3%	2.1%	Capital Goods
	SNG	€2.09	0%	-29.4%	€109.3m	n/a	18.1	n/a	1.9%	Software
	VYT	€16.85	-5.3%	206.4%	€126.7m	n/a	43.7	n/a	n/a	Household
	ITX	€58.18	2.4%	40.9%	€181.2b	€59.54	28.8	8.5%	3.0%	Retail
	APG	€17.70	4.1%	11.3%	€92.2m	n/a	14.5	12.3%	5.0%	Diversified Financials
	ENO	€33.70	2.0%	44.6%	€2.9b	€41.88	22.2	11.8%	1.6%	Capital Goods
	BST	€0.23	6.0%	-33.2%	€17.0m	n/a	5.0	n/a	n/a	Pharmaceuticals & Biotech
	ALM	€10.96	-6.0%	6.0%	€2.4b	€14.51	40.4	25.7%	1.7%	Pharmaceuticals & Biotech
	REP	€25.74	1.8%	96.9%	€28.1b	€27.08	8.2	-6.3%	4.2%	Energy
	AYC	€0.55	0%	-4.4%	€18.1m	n/a	4.9	n/a	n/a	Real Estate Management and Development
	TRH	€1.00	0%	0%	€300.0k	n/a	0.3	n/a	n/a	Consumer Services
	A3M	€5.12	-2.7%	3.3%	€1.2b	€5.47	21.1	15.9%	7.6%	Media
	GSJ	€8.12	1.9%	34.0%	€528.0m	€10.08	11.5	-3.1%	2.2%	Capital Goods
	GRI	€1.63	5.8%	53.8%	€49.5m	n/a	20.5	n/a	n/a	Commercial Services

Page 1 of 3